| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Opportunistic Infections | 2 | 2019 | 602 | 0.97 | Why? |
| Pneumocystis Infections | 1 | 2019 | 10 | 0.82 | Why? |
| Antigens, Surface | 2 | 2018 | 181 | 0.82 | Why? |
| CD52 Antigen | 1 | 2018 | 6 | 0.75 | Why? |
| Antigens, CD19 | 1 | 2018 | 98 | 0.70 | Why? |
| Antigens, CD20 | 1 | 2018 | 105 | 0.69 | Why? |
| Communicable Diseases | 6 | 2018 | 2148 | 0.65 | Why? |
| Biological Therapy | 2 | 2018 | 456 | 0.63 | Why? |
| Fever of Unknown Origin | 1 | 2017 | 93 | 0.62 | Why? |
| Immunocompromised Host | 5 | 2019 | 5150 | 0.61 | Why? |
| Infectious Disease Medicine | 1 | 2018 | 311 | 0.57 | Why? |
| Specialization | 2 | 2018 | 432 | 0.57 | Why? |
| Carbapenem-Resistant Enterobacteriaceae | 1 | 2017 | 214 | 0.57 | Why? |
| Pneumonia, Pneumocystis | 1 | 2019 | 322 | 0.56 | Why? |
| Germany | 14 | 2021 | 9196 | 0.55 | Why? |
| Enterobacteriaceae | 1 | 2017 | 395 | 0.52 | Why? |
| Internal Medicine | 1 | 2018 | 557 | 0.46 | Why? |
| Molecular Targeted Therapy | 2 | 2018 | 1579 | 0.46 | Why? |
| Herpes Zoster | 1 | 2017 | 331 | 0.46 | Why? |
| Influenza Vaccines | 2 | 2018 | 2941 | 0.45 | Why? |
| Intestines | 1 | 2017 | 817 | 0.43 | Why? |
| Journal Impact Factor | 1 | 2012 | 134 | 0.42 | Why? |
| Emigration and Immigration | 1 | 2016 | 501 | 0.42 | Why? |
| Influenza, Human | 3 | 2018 | 10779 | 0.38 | Why? |
| Seasons | 2 | 2018 | 4071 | 0.36 | Why? |
| Cost-Benefit Analysis | 1 | 2017 | 2259 | 0.33 | Why? |
| Microbiota | 1 | 2017 | 1240 | 0.32 | Why? |
| Mass Vaccination | 1 | 2016 | 1101 | 0.30 | Why? |
| Communicable Disease Control | 6 | 2020 | 29620 | 0.27 | Why? |
| Transients and Migrants | 1 | 2016 | 1468 | 0.26 | Why? |
| Bacterial Infections | 1 | 2017 | 2229 | 0.26 | Why? |
| Sepsis | 1 | 2019 | 3517 | 0.24 | Why? |
| Fecal Microbiota Transplantation | 2 | 2017 | 372 | 0.24 | Why? |
| Age Distribution | 2 | 2021 | 3567 | 0.21 | Why? |
| Hepatolenticular Degeneration | 1 | 2021 | 62 | 0.21 | Why? |
| Cross Infection | 3 | 2020 | 8675 | 0.20 | Why? |
| Clostridium Infections | 2 | 2017 | 595 | 0.20 | Why? |
| Borna Disease | 1 | 2018 | 3 | 0.20 | Why? |
| Borna disease virus | 1 | 2018 | 3 | 0.20 | Why? |
| Lung Diseases, Fungal | 1 | 2021 | 167 | 0.20 | Why? |
| Anti-Bacterial Agents | 5 | 2019 | 10083 | 0.19 | Why? |
| Viral Interference | 1 | 2018 | 33 | 0.19 | Why? |
| Periodicals as Topic | 1 | 2012 | 1492 | 0.19 | Why? |
| Flaviviridae | 1 | 2018 | 60 | 0.19 | Why? |
| Basic Reproduction Number | 2 | 2020 | 2676 | 0.18 | Why? |
| Trimethoprim, Sulfamethoxazole Drug Combination | 1 | 2019 | 170 | 0.18 | Why? |
| Disease Outbreaks | 3 | 2021 | 27595 | 0.18 | Why? |
| Humans | 46 | 2022 | 930598 | 0.17 | Why? |
| Antibodies, Monoclonal, Murine-Derived | 1 | 2018 | 94 | 0.17 | Why? |
| Transplants | 1 | 2018 | 136 | 0.17 | Why? |
| Pneumocystis carinii | 1 | 2019 | 205 | 0.16 | Why? |
| Tertiary Healthcare | 1 | 2021 | 616 | 0.16 | Why? |
| Endocarditis | 2 | 2019 | 368 | 0.16 | Why? |
| Sulfur Hexafluoride | 2 | 2017 | 15 | 0.16 | Why? |
| Mandatory Testing | 1 | 2016 | 67 | 0.15 | Why? |
| Gram-Positive Bacterial Infections | 1 | 2019 | 323 | 0.15 | Why? |
| Unnecessary Procedures | 1 | 2017 | 175 | 0.14 | Why? |
| HIV Infections | 2 | 2019 | 11620 | 0.14 | Why? |
| Gram-Negative Bacterial Infections | 1 | 2019 | 398 | 0.14 | Why? |
| Encephalitis, Viral | 1 | 2018 | 355 | 0.13 | Why? |
| Coronavirus Infections | 8 | 2020 | 253789 | 0.13 | Why? |
| Escherichia coli Infections | 1 | 2018 | 348 | 0.13 | Why? |
| Pneumonia, Viral | 7 | 2020 | 243684 | 0.13 | Why? |
| Phospholipids | 2 | 2017 | 202 | 0.13 | Why? |
| Drug Resistance, Microbial | 1 | 2018 | 419 | 0.13 | Why? |
| Perinatal Care | 1 | 2020 | 576 | 0.13 | Why? |
| Immunologic Deficiency Syndromes | 1 | 2017 | 368 | 0.13 | Why? |
| Sex Distribution | 1 | 2021 | 2083 | 0.13 | Why? |
| Evidence-Based Medicine | 2 | 2017 | 3228 | 0.13 | Why? |
| Pharynx | 1 | 2021 | 1544 | 0.13 | Why? |
| Feces | 2 | 2017 | 4235 | 0.13 | Why? |
| Virus Activation | 1 | 2018 | 480 | 0.13 | Why? |
| Ceftriaxone | 1 | 2015 | 365 | 0.13 | Why? |
| Infectious Disease Incubation Period | 1 | 2020 | 1033 | 0.12 | Why? |
| Mycoses | 1 | 2019 | 589 | 0.12 | Why? |
| Energy Metabolism | 1 | 2017 | 451 | 0.12 | Why? |
| Liver Neoplasms | 2 | 2017 | 1666 | 0.12 | Why? |
| Lymphohistiocytosis, Hemophagocytic | 1 | 2021 | 800 | 0.12 | Why? |
| History, 20th Century | 1 | 2018 | 1282 | 0.12 | Why? |
| Incidence | 4 | 2021 | 25622 | 0.12 | Why? |
| Urinary Tract Infections | 1 | 2018 | 534 | 0.12 | Why? |
| Liver Circulation | 1 | 2011 | 12 | 0.11 | Why? |
| Seroconversion | 1 | 2022 | 2515 | 0.11 | Why? |
| Enterobacteriaceae Infections | 1 | 2017 | 529 | 0.11 | Why? |
| Adipose Tissue | 1 | 2017 | 612 | 0.11 | Why? |
| Attitude | 1 | 2021 | 1481 | 0.11 | Why? |
| Practice Guidelines as Topic | 1 | 2016 | 15421 | 0.11 | Why? |
| Metabolic Diseases | 1 | 2017 | 505 | 0.11 | Why? |
| Biological Science Disciplines | 1 | 2012 | 72 | 0.11 | Why? |
| Serum Albumin | 1 | 2015 | 571 | 0.11 | Why? |
| Lymphocyte Activation | 1 | 2021 | 2742 | 0.11 | Why? |
| Microbubbles | 1 | 2011 | 40 | 0.11 | Why? |
| beta-Lactamases | 1 | 2017 | 759 | 0.11 | Why? |
| Vaccination | 4 | 2021 | 19050 | 0.10 | Why? |
| Pneumonia, Bacterial | 1 | 2017 | 843 | 0.10 | Why? |
| Staphylococcus aureus | 1 | 2017 | 844 | 0.10 | Why? |
| Multiple Organ Failure | 1 | 2021 | 1724 | 0.10 | Why? |
| Enzyme-Linked Immunosorbent Assay | 3 | 2021 | 7868 | 0.10 | Why? |
| Viral Tropism | 1 | 2018 | 1329 | 0.10 | Why? |
| Antibiotics, Antineoplastic | 1 | 2011 | 128 | 0.10 | Why? |
| Escherichia coli | 1 | 2018 | 1547 | 0.10 | Why? |
| Rituximab | 1 | 2018 | 1096 | 0.10 | Why? |
| Chemoembolization, Therapeutic | 1 | 2011 | 144 | 0.10 | Why? |
| Antimicrobial Stewardship | 1 | 2018 | 931 | 0.10 | Why? |
| Forecasting | 2 | 2020 | 4492 | 0.10 | Why? |
| Contrast Media | 2 | 2017 | 1011 | 0.10 | Why? |
| Critical Illness | 4 | 2021 | 17281 | 0.09 | Why? |
| China | 3 | 2020 | 50654 | 0.09 | Why? |
| Bacterial Proteins | 1 | 2017 | 1318 | 0.09 | Why? |
| Doxorubicin | 1 | 2011 | 313 | 0.09 | Why? |
| Microbial Sensitivity Tests | 1 | 2017 | 2886 | 0.09 | Why? |
| Lymphocytes | 2 | 2018 | 3056 | 0.09 | Why? |
| Drug Resistance, Bacterial | 1 | 2018 | 1414 | 0.09 | Why? |
| Cause of Death | 2 | 2021 | 4823 | 0.08 | Why? |
| Staphylococcal Infections | 1 | 2017 | 1099 | 0.08 | Why? |
| Risk Factors | 4 | 2021 | 71621 | 0.08 | Why? |
| Cross-Sectional Studies | 5 | 2021 | 53120 | 0.08 | Why? |
| Time Factors | 5 | 2021 | 31397 | 0.08 | Why? |
| Neutralization Tests | 1 | 2020 | 6698 | 0.08 | Why? |
| Antigens, Viral | 2 | 2022 | 6298 | 0.08 | Why? |
| Microcirculation | 1 | 2011 | 447 | 0.08 | Why? |
| Bacteremia | 1 | 2017 | 1372 | 0.08 | Why? |
| Diagnosis, Differential | 2 | 2021 | 7220 | 0.08 | Why? |
| Infant | 2 | 2021 | 30274 | 0.08 | Why? |
| Antiviral Agents | 2 | 2020 | 41703 | 0.08 | Why? |
| Consensus | 2 | 2018 | 6345 | 0.08 | Why? |
| Betacoronavirus | 6 | 2020 | 204454 | 0.08 | Why? |
| Liver | 1 | 2021 | 4007 | 0.08 | Why? |
| Ultrasonography, Interventional | 1 | 2011 | 560 | 0.08 | Why? |
| Geography | 1 | 2012 | 1801 | 0.08 | Why? |
| Hospitals, University | 1 | 2018 | 4173 | 0.07 | Why? |
| Software | 1 | 2017 | 2501 | 0.07 | Why? |
| Extracorporeal Membrane Oxygenation | 2 | 2021 | 5002 | 0.07 | Why? |
| Child, Preschool | 2 | 2021 | 36283 | 0.07 | Why? |
| Young Adult | 6 | 2021 | 93724 | 0.07 | Why? |
| Feeding Behavior | 1 | 2017 | 1909 | 0.07 | Why? |
| Hospitals | 2 | 2021 | 11793 | 0.07 | Why? |
| Adult | 11 | 2022 | 244371 | 0.07 | Why? |
| Pandemics | 8 | 2020 | 389249 | 0.07 | Why? |
| Biomedical Research | 2 | 2017 | 5270 | 0.07 | Why? |
| Curriculum | 1 | 2018 | 3083 | 0.07 | Why? |
| Viral Load | 2 | 2022 | 15850 | 0.07 | Why? |
| Gastrointestinal Microbiome | 1 | 2017 | 1961 | 0.07 | Why? |
| Hospitalization | 3 | 2021 | 54280 | 0.07 | Why? |
| Education, Medical, Graduate | 1 | 2018 | 2082 | 0.06 | Why? |
| T-Lymphocytes | 1 | 2021 | 6670 | 0.06 | Why? |
| Communicable Diseases, Emerging | 1 | 2018 | 2523 | 0.06 | Why? |
| Mortality | 1 | 2020 | 7132 | 0.06 | Why? |
| Autoimmune Diseases | 1 | 2017 | 1996 | 0.06 | Why? |
| Female | 16 | 2022 | 380317 | 0.06 | Why? |
| HIV-1 | 1 | 2018 | 3365 | 0.06 | Why? |
| Health Promotion | 1 | 2017 | 2020 | 0.06 | Why? |
| Specimen Handling | 1 | 2021 | 6190 | 0.06 | Why? |
| Internationality | 1 | 2016 | 3297 | 0.06 | Why? |
| Aged | 11 | 2021 | 215776 | 0.06 | Why? |
| Middle Aged | 12 | 2021 | 270681 | 0.06 | Why? |
| Inpatients | 1 | 2018 | 5161 | 0.06 | Why? |
| Referral and Consultation | 1 | 2018 | 4816 | 0.06 | Why? |
| Societies, Medical | 1 | 2018 | 6907 | 0.06 | Why? |
| Publishing | 1 | 2012 | 990 | 0.06 | Why? |
| Clinical Trials as Topic | 2 | 2018 | 7330 | 0.06 | Why? |
| Immunologic Factors | 1 | 2018 | 4206 | 0.06 | Why? |
| Travel | 1 | 2020 | 7220 | 0.06 | Why? |
| Isosporiasis | 1 | 2000 | 3 | 0.06 | Why? |
| Isospora | 1 | 2000 | 5 | 0.06 | Why? |
| Cross-Cultural Comparison | 1 | 2004 | 338 | 0.06 | Why? |
| Lung | 2 | 2021 | 31049 | 0.06 | Why? |
| Ultrasonography | 1 | 2017 | 4409 | 0.05 | Why? |
| RNA, Ribosomal | 1 | 2000 | 39 | 0.05 | Why? |
| Brain | 1 | 2018 | 5133 | 0.05 | Why? |
| Pneumonia | 1 | 2021 | 5652 | 0.05 | Why? |
| Basophils | 1 | 2021 | 179 | 0.05 | Why? |
| Coinfection | 1 | 2021 | 6820 | 0.05 | Why? |
| Adolescent | 3 | 2021 | 86841 | 0.05 | Why? |
| Carcinoma, Hepatocellular | 1 | 2011 | 1222 | 0.05 | Why? |
| Cohort Studies | 2 | 2021 | 36005 | 0.05 | Why? |
| Virus Diseases | 1 | 2018 | 3779 | 0.05 | Why? |
| Child | 2 | 2021 | 70012 | 0.05 | Why? |
| Antibodies, Viral | 3 | 2022 | 51949 | 0.05 | Why? |
| Virus Internalization | 1 | 2018 | 7921 | 0.05 | Why? |
| Hospitals, Maternity | 1 | 2020 | 154 | 0.05 | Why? |
| Sialic Acid Binding Ig-like Lectin 2 | 1 | 2018 | 7 | 0.05 | Why? |
| Sialic Acid Binding Ig-like Lectin 3 | 1 | 2018 | 4 | 0.05 | Why? |
| Virus Replication | 1 | 2020 | 14331 | 0.05 | Why? |
| Immunoglobulin A | 2 | 2021 | 3567 | 0.05 | Why? |
| Signaling Lymphocytic Activation Molecule Family | 1 | 2018 | 22 | 0.05 | Why? |
| Ki-1 Antigen | 1 | 2018 | 25 | 0.05 | Why? |
| Immunity, Innate | 1 | 2017 | 6570 | 0.05 | Why? |
| Receptors, CCR4 | 1 | 2018 | 42 | 0.05 | Why? |
| Male | 13 | 2022 | 367725 | 0.05 | Why? |
| Inflammation | 1 | 2021 | 13255 | 0.05 | Why? |
| ADP-ribosyl Cyclase 1 | 1 | 2018 | 96 | 0.04 | Why? |
| 3T3-L1 Cells | 1 | 2017 | 29 | 0.04 | Why? |
| Retrospective Studies | 5 | 2021 | 105322 | 0.04 | Why? |
| Global Health | 2 | 2017 | 13911 | 0.04 | Why? |
| CD40 Antigens | 1 | 2018 | 118 | 0.04 | Why? |
| Aged, 80 and over | 4 | 2021 | 88759 | 0.04 | Why? |
| Epidemics | 1 | 2017 | 6407 | 0.04 | Why? |
| Macrophage Activation Syndrome | 1 | 2021 | 342 | 0.04 | Why? |
| Surveys and Questionnaires | 2 | 2021 | 43792 | 0.04 | Why? |
| Adipokines | 1 | 2017 | 87 | 0.04 | Why? |
| Infant, Newborn | 1 | 2017 | 23105 | 0.04 | Why? |
| Immune Sera | 1 | 2020 | 884 | 0.04 | Why? |
| Gram-Positive Bacteria | 1 | 2017 | 230 | 0.04 | Why? |
| Metabolic Clearance Rate | 1 | 2015 | 110 | 0.04 | Why? |
| Heart Diseases | 1 | 2012 | 3503 | 0.04 | Why? |
| Peritonitis | 1 | 2017 | 217 | 0.03 | Why? |
| Endocarditis, Bacterial | 1 | 2019 | 344 | 0.03 | Why? |
| Tomography, X-Ray Computed | 1 | 2020 | 25144 | 0.03 | Why? |
| Immunoglobulin M | 2 | 2021 | 9091 | 0.03 | Why? |
| Emergency Service, Hospital | 1 | 2018 | 14232 | 0.03 | Why? |
| Myeloid Cells | 1 | 2018 | 808 | 0.03 | Why? |
| Dendritic Cells | 1 | 2021 | 1330 | 0.03 | Why? |
| Health Services Accessibility | 1 | 2016 | 10697 | 0.03 | Why? |
| Infusions, Intra-Arterial | 1 | 2011 | 36 | 0.03 | Why? |
| Ultrasonography, Doppler, Color | 1 | 2011 | 107 | 0.03 | Why? |
| Neoplasm Recurrence, Local | 1 | 2017 | 1063 | 0.03 | Why? |
| Spike Glycoprotein, Coronavirus | 1 | 2020 | 37182 | 0.02 | Why? |
| Cells, Cultured | 1 | 2021 | 5835 | 0.02 | Why? |
| Health Personnel | 1 | 2020 | 29646 | 0.02 | Why? |
| Sensitivity and Specificity | 2 | 2021 | 22971 | 0.02 | Why? |
| Hand Hygiene | 1 | 2020 | 1493 | 0.02 | Why? |
| Microspheres | 1 | 2011 | 261 | 0.02 | Why? |
| Rats | 1 | 2017 | 2764 | 0.02 | Why? |
| Glomerular Filtration Rate | 1 | 2015 | 1262 | 0.02 | Why? |
| Radiography, Interventional | 1 | 2011 | 158 | 0.02 | Why? |
| Membrane Glycoproteins | 1 | 2018 | 2273 | 0.02 | Why? |
| Fatal Outcome | 1 | 2018 | 3438 | 0.02 | Why? |
| RNA, Viral | 3 | 2022 | 32276 | 0.02 | Why? |
| Monocytes | 1 | 2021 | 2978 | 0.02 | Why? |
| Multidetector Computed Tomography | 1 | 2011 | 307 | 0.02 | Why? |
| Protein Domains | 1 | 2020 | 6563 | 0.02 | Why? |
| Treatment Outcome | 3 | 2021 | 51732 | 0.02 | Why? |
| Immunoglobulin G | 2 | 2021 | 21571 | 0.02 | Why? |
| Infusions, Intravenous | 1 | 2011 | 1224 | 0.02 | Why? |
| Oxygen | 1 | 2020 | 3715 | 0.02 | Why? |
| Peptides | 1 | 2018 | 2513 | 0.02 | Why? |
| Mice, Inbred C57BL | 1 | 2017 | 5542 | 0.02 | Why? |
| Viral Envelope Proteins | 1 | 2018 | 3539 | 0.02 | Why? |
| Dose-Response Relationship, Drug | 1 | 2015 | 3776 | 0.02 | Why? |
| Polymerase Chain Reaction | 1 | 2000 | 6740 | 0.02 | Why? |
| Saliva | 1 | 2021 | 4679 | 0.02 | Why? |
| Neutrophils | 1 | 2021 | 5476 | 0.02 | Why? |
| Zoonoses | 1 | 2018 | 3034 | 0.02 | Why? |
| Algorithms | 1 | 2021 | 7346 | 0.02 | Why? |
| Public Health | 2 | 2022 | 16359 | 0.02 | Why? |
| Severity of Illness Index | 2 | 2022 | 48226 | 0.02 | Why? |
| Liver Transplantation | 1 | 2018 | 2864 | 0.02 | Why? |
| Magnetic Resonance Imaging | 1 | 2018 | 6551 | 0.01 | Why? |
| Receptors, Virus | 1 | 2018 | 5659 | 0.01 | Why? |
| Blotting, Southern | 1 | 2000 | 18 | 0.01 | Why? |
| Intensive Care Units | 2 | 2021 | 29594 | 0.01 | Why? |
| Disease Progression | 1 | 2020 | 13580 | 0.01 | Why? |
| DNA, Protozoan | 1 | 2000 | 77 | 0.01 | Why? |
| United Kingdom | 1 | 2021 | 18046 | 0.01 | Why? |
| Computer Simulation | 1 | 2015 | 4982 | 0.01 | Why? |
| Animals | 3 | 2018 | 78931 | 0.01 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2004 | 12361 | 0.01 | Why? |
| Social Isolation | 1 | 2020 | 5932 | 0.01 | Why? |
| Phylogeny | 1 | 2018 | 13341 | 0.01 | Why? |
| Protein Binding | 1 | 2015 | 11430 | 0.01 | Why? |
| Kidney Transplantation | 1 | 2018 | 5397 | 0.01 | Why? |
| Pregnancy | 1 | 2020 | 23879 | 0.01 | Why? |
| Masks | 1 | 2020 | 8528 | 0.01 | Why? |
| Mice | 1 | 2017 | 21357 | 0.01 | Why? |
| Prognosis | 1 | 2021 | 32490 | 0.01 | Why? |
| DNA Primers | 1 | 2000 | 1170 | 0.01 | Why? |
| Comorbidity | 1 | 2019 | 34796 | 0.01 | Why? |
| Cytokines | 1 | 2017 | 15010 | 0.01 | Why? |
| Antibodies, Neutralizing | 1 | 2020 | 25288 | 0.01 | Why? |
| Quarantine | 1 | 2020 | 18418 | 0.01 | Why? |
| Delivery of Health Care | 1 | 2017 | 15909 | 0.01 | Why? |